The ability to assess levels of multiple complement proteins simultaneously in patient serum or plasma to determine “complement profiles” of disease would be of great value. Until now, researchers could assay only individual complement components using ELISAs.
New technologies have allowed for the development of two complement panels, based on dilution factors, to determine levels of 15 key complement proteins simultaneously in serum or plasma. | 
